| The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial AA Voors, CE Angermann, JR Teerlink, SP Collins, M Kosiborod, J Biegus, ... Nature medicine 28 (3), 568-574, 2022 | 747 | 2022 |
| Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart … EA Jankowska, M Kasztura, M Sokolski, M Bronisz, S Nawrocka, ... European heart journal 35 (36), 2468-2476, 2014 | 295 | 2014 |
| Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial J Biegus, AA Voors, SP Collins, MN Kosiborod, JR Teerlink, ... European heart journal 44 (1), 41-50, 2023 | 152 | 2023 |
| Increased blood lactate is prevalent and identifies poor prognosis in patients with acute heart failure without overt peripheral hypoperfusion R Zymliński, J Biegus, M Sokolski, P Siwołowski, S Nawrocka‐Millward, ... European journal of heart failure 20 (6), 1011-1018, 2018 | 144 | 2018 |
| Effects of empagliflozin on symptoms, physical limitations, and quality of life in patients hospitalized for acute heart failure: results from the EMPULSE trial MN Kosiborod, CE Angermann, SP Collins, JR Teerlink, P Ponikowski, ... Circulation 146 (4), 279-288, 2022 | 129 | 2022 |
| Sodium–glucose co‐transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial J Tromp, P Ponikowski, A Salsali, CE Angermann, J Biegus, J Blatchford, ... European Journal of Heart Failure 23 (5), 826-834, 2021 | 117 | 2021 |
| Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study J Biegus, HL Hillege, D Postmus, MAE Valente, DM Bloomfield, ... European journal of heart failure 18 (7), 830-839, 2016 | 115 | 2016 |
| Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology J Núñez, R de la Espriella, P Rossignol, AA Voors, W Mullens, M Metra, ... European journal of heart failure 24 (10), 1751-1766, 2022 | 106 | 2022 |
| Serial assessment of spot urine sodium predicts effectiveness of decongestion and outcome in patients with acute heart failure J Biegus, R Zymliński, M Sokolski, J Todd, G Cotter, M Metra, ... European journal of heart failure 21 (5), 624-633, 2019 | 100 | 2019 |
| Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology MF Piepoli, M Adamo, A Barison, RB Bestetti, J Biegus, M Böhm, J Butler, ... European journal of preventive cardiology 29 (1), 275-300, 2022 | 93 | 2022 |
| Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure M Sokolski, R Zymliński, J Biegus, P Siwołowski, S Nawrocka‐Millward, ... European journal of heart failure 19 (6), 760-767, 2017 | 80 | 2017 |
| Impaired hepato‐renal function defined by the MELD XI score as prognosticator in acute heart failure J Biegus, R Zymliński, M Sokolski, P Siwołowski, P Gajewski, ... European journal of heart failure 18 (12), 1518-1521, 2016 | 79 | 2016 |
| Impact of coronavirus disease 2019 (COVID-19) outbreak on acute admissions at the emergency and cardiology departments across Europe M Sokolski, P Gajewski, R Zymliński, J Biegus, JM Ten Berg, W Bor, ... The American journal of medicine 134 (4), 482-489, 2021 | 76 | 2021 |
| Liver function tests in patients with acute heart failure J Biegus, R Zymlinski, M Sokolski, S Nawrocka, P Siwołowski, ... Pol Arch Med Wewn 122 (10), 471-479, 2012 | 68 | 2012 |
| Renal profiling based on estimated glomerular filtration rate and spot urine sodium identifies high‐risk acute heart failure patients J Biegus, R Zymliński, J Testani, D Marciniak, A Zdanowicz, ... European journal of heart failure 23 (5), 729-739, 2021 | 60 | 2021 |
| Multi‐organ dysfunction/injury on admission identifies acute heart failure patients at high risk of poor outcome R Zymliński, M Sokolski, J Biegus, P Siwołowski, S Nawrocka‐Millward, ... European journal of heart failure 21 (6), 744-750, 2019 | 56 | 2019 |
| Comparison of invasive and non-invasive measurements of haemodynamic parameters in patients with advanced heart failure M Sokolski, A Rydlewska, B Krakowiak, J Biegus, R Zymlinski, ... Journal of cardiovascular medicine 12 (11), 773-778, 2011 | 56 | 2011 |
| NT-proBNP and high intensity care for acute heart failure: the STRONG-HF trial M Adamo, M Pagnesi, A Mebazaa, B Davison, C Edwards, D Tomasoni, ... European Heart Journal 44 (31), 2947-2962, 2023 | 49 | 2023 |
| Molekularne podstawy angiogenezy J Skóra, J Biegus, A Pupka, P Barć, J Sikora, P Szyber Postępy Higieny i Medycyny Doświadczalnej 60, 2006 | 48* | 2006 |
| Renal effects of empagliflozin in patients hospitalized for acute heart failure: from the EMPULSE trial AA Voors, K Damman, JR Teerlink, CE Angermann, SP Collins, ... European journal of heart failure 24 (10), 1844-1852, 2022 | 46 | 2022 |
Ponikowski PMedical University, Wroclaw, Polandumed.wroc.pl üzerinde doğrulanmış e-posta adresine sahip